Evidence Hub

Electrospun Zn-cobimetinib-levofloxacin-PVA/PVP nanofibers for skin-targeted anticancer and antimicrobial applications

Talib ZA, Aldulaimi AKO, Altalbawy FMA, Altalbawy FMA, Sulaiman JMA, Albadr RJ, Mohammed Taher W, Abd NS et al.

RSC advances, 2026

Abstract

The development of wound dressings that simultaneously combat skin cancer and prevent bacterial infection remains an unmet clinical need. Herein, we report electrospun nanofibrous composites composed of polyvinyl alcohol (PVA) and polyvinyl pyrrolidone (PVP) co-loaded with cobimetinib, levofloxacin, and zinc nitrate. Cobimetinib's tetradentate coordination enabled the formation of a stable Zn-based coordination complex within the polymeric matrix (Zn-cobimetinib-levofloxacin-PVA/PVP nanofibers), ensuring stable incorporation of the drugs while preserving their biological activity. Physicochemical characterization, including scanning electron microscopy (SEM), energy eispersive X-ray (EDX), Fourier-transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), thermogravimetric analysis (TGA), differential thermogravimetric (DTG), differential scanning calorimetry (DSC), ultraviolet and visible-spectroscopy (UV-vis), tensile strength, contact angle, N2 adsorption-desorption isotherm, confirmed uniform fiber morphology, structural integrity, and retention of chemical functionalities. Biological evaluations showed that the nanofibers reduced the viability of A431 skin carcinoma cells by approximately 70% after 48 h under the tested conditions and antimicrobial efficacy with MIC of 2 to 64 µg mL-1 against clinically relevant pathogens. The results highlight the synergistic multifunctionality of the composite, establishing it as a electrospun platform for skin wound dressings…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free